News
Media
Multimedia Series
Conferences
Partners
CME/CE
Resources
Advisory Board
Subscribe

Spotlight -

This Year In Medicine 2025

Frank C. Sciurba, MD

Articles by Frank C. Sciurba, MD

OBERON and TITANIA Showcase Tozorakimab's Emerging Benefit for COPD, With Frank Sciurba, MD

OBERON and TITANIA Showcase Tozorakimab's Emerging Benefit for COPD, With Frank Sciurba, MD

ByFrank C. Sciurba, MD

April 27th 2026

The phase 3 trials enrolled frequent exacerbators regardless of eosinophil count or smoking status.

Reducing COPD Exacerbations With Tozorakimab, With Frank Sciurba, MD

Reducing COPD Exacerbations With Tozorakimab, With Frank Sciurba, MD

ByFrank C. Sciurba, MD

April 17th 2026

Tozorakimab significantly reduced moderate-to-severe exacerbations in COPD regardless of blood eosinophil count.

Expanding Precision Medicine in COPD With Mepolizumab, with Frank Sciurba, MD

Expanding Precision Medicine in COPD With Mepolizumab, with Frank Sciurba, MD

ByFrank C. Sciurba, MD

June 4th 2025

Sciurba shared his excitement for the recent approval of mepolizumab for people with COPD and an eosinophilic phenotype.

Latest Updated Articles

Trending on HCPLive

SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study

Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B

Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial

Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs

What Are the Side Effects of Hair and Skin Supplements in Dermatology? With Rajani Katta, MD